Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Triethyl O-acetylcitrate has a history dating back to the search for safer, nontoxic plasticizers in pharmaceutical and food-contact materials. Early plasticizers often relied on phthalates or camphor derivatives, which led to concerns about toxicity or tainting of flavors. Researchers in the mid-20th century began exploring citrate esters as alternatives. By focusing on molecules such as triethyl citrate and its acetylated cousin, scientists saw an opportunity for better stability, lower odor, and improved safety. The compound’s development ran in parallel with advancements in analytical chemistry, which allowed teams to screen materials for endocrine disruption, carcinogenicity, and slow decomposition. Pharmaceutical standards, like those in the BP, EP, and USP monographs, grew stricter thanks to this background. Triethyl O-acetylcitrate gradually replaced earlier options in the formulation of coated tablets, sustained-release formulations, and soft gelatin capsules.
Triethyl O-acetylcitrate stands out because it crosses the boundaries between pharma, food, and polymer science. This clear or pale yellow liquid shows up as an excipient for tablet coatings, as a flexibility enhancer for enteric polymers, and even as a food-contact plasticizer in packaging films. Most pharma companies adopt it due to a blend of high purity, low toxicity, and compliance with key pharmacopoeia standards. Labeling usually states “for pharmaceutical use,” with references to BP, EP, and USP specifications. It often ships in drums or coated totes, protected from air and moisture.
This compound features a molecular formula of C14H22O8, which gives it a molar mass just over 318 grams per mole. Its structure includes a citric acid core where three ethyl groups and one acetyl group attach through ester bonds. The acetylation helps block unwanted hydrolysis and raises its boiling point above 150°C at reduced pressure. At room temperature, it stays liquid, displaying miscibility with acetone, chloroform, and alcohol while showing poor solubility in water. Its refractive index sits around 1.428–1.432, and density typically measures near 1.14–1.17 g/mL. Labs measure its acidity (often below 0.2%), water content (usually less than 0.5%), and heavy metal profile, all key for pharmaceutical formulations.
Suppliers produce Triethyl O-acetylcitrate to match benchmarks set by pharmacopeial monographs. Key numbers arise in documents: assay readings above 98%, low color index, peroxide values beneath pharmacopeial limits, and a full certificate of analysis on each lot. Labels feature the chemical name, batch number, net volume or weight, storage instructions (“cool, dry, away from sunlight”), and conformity to BP, EP, and USP. Many buyers demand a substance free from phthalate contamination with clear records for elemental impurities and residual solvents. Storage typically occurs in tightly sealed containers due to the product’s mild hygroscopicity and risk of hydrolysis over long periods.
Manufacturers start synthesis from citric acid, which undergoes an esterification process using ethanol under acid catalysis, producing triethyl citrate. Then, acetylation steps in through either acetic anhydride or acetyl chloride, transforming the terminal hydroxyl group into an acetoxy moiety. Careful temperature control prevents over-acetylation or the generation of byproducts. Purification by vacuum distillation, multiple aqueous washes, and solid phase extraction steps ensure the removal of acidic residues and unreacted acetic species. This streamlined process balances cost, yield, and purity—facilitating scale-up for pharma-grade production.
Triethyl O-acetylcitrate holds up well to mild acids and bases but can break down under strong alkaline or acidic conditions through hydrolysis, liberating acetic and citric acid. Its ester groups allow some flexibility in chemical transformations: deacetylation, partial saponification, or further ester substitutions, if required for laboratory studies. Complexation with certain cations can shift physical properties, which researchers sometimes study to assess compatibility with active drug ingredients or packaging materials. In real-world pharma use, its main advantage lies in “inertness,” resisting unwanted decomposition at normal processing temperatures.
Industry professionals use several names for this compound: Acetyl triethylcitrate, TEC acetyl, and 1,2,3-propanetricarboxylic acid, 2-(acetyloxy)-, tributyl ester. Some supply catalogs might list “Citrate acetyltriethyl ester,” drawing from IUPAC conventions. Most pharma-grade suppliers stick to “Triethyl O-acetylcitrate BP/EP/USP,” for clarity and regulatory compliance.
Handling guidelines emphasize eye and skin protection, ventilation of production and packing rooms, and spill control with absorbent materials. Acute toxicity remains low, as supported by animal studies reporting high LD50 values. Chronic exposure through inhalation or skin contact has not triggered major red flags, but responsible operations still monitor workplace levels. Because it degrades slowly into citric and acetic acids, environmental persistence does not rival that of phthalate plasticizers. Both the FDA and EMA tolerate its use in a range of oral and topical drug products, some food contact applications, and dietary supplement formulations. The degree of oversight grows when manufacturers plan for high-dose exposure, pediatric, or chronic therapies.
Triethyl O-acetylcitrate finds its way into film-coating systems for tablets, offering flexibility to avoid cracks, even when stored for months in harsh climates. Formulators use it to fine-tune the dissolution profile of sustained-release coatings, balancing brittleness and permeability. In soft gel capsules, it supports shell integrity alongside gelatin and other co-plasticizers, especially for drugs sensitive to temperature or humidity. Outside pharma, it plays a background role in biodegradable packaging, compostable plastics, and even as a conditionally approved food-contact agent. Many animal-feed pellet coatings and veterinary medicines also rely on its robust safety profile.
Academic and industry labs frequently study this compound as a model for new excipients, asking whether acetylation or other structural tweaks yield better compatibility or release kinetics. Publications increasingly describe its behavior in hot-melt extrusion technology, nanoparticle encapsulation, and the building of specialty polymer blends for challenging drugs. The fact that regulators recognize it in the main pharmacopoeias means researchers can often skip added toxicology hurdles, accelerating development. Several recent patents focus on its use in enteric coatings, contrasting its migration, taste-masking effects, and processing stability against both older phthalates and newer, more exotic designs.
Numerous rat and mouse studies address acute, sub-chronic, and reproductive toxicity. Doses far above those employed in finished products failed to trigger teratogenic or carcinogenic outcomes. In-vitro tests display no mutagenic signatures, with standard Ames assay and cell line work supporting low genotoxic risk. Metabolic fate studies prove rapid breakdown to harmless metabolites, excreted as either citric or acetic acid. One recurring theme is that repeated dosing did not accumulate in tissues or alter typical enzymatic functions, which matches day-to-day experience in pharmaceutical manufacturing. Concerns around impurities, rather than the parent molecule, have seen more discussion in public safety reviews, which drives continued pressure for stringent purification.
Excipient innovation rarely grabs headlines, but pressure for greener, safer, and more sustainable plasticizers keeps companies scouting for new options or tweaks to old favorites. Triethyl O-acetylcitrate’s flexibility still meets many demands, especially with regulatory confidence and plenty of toxicology history on its side. Formulators in oral, transdermal, and depot-injection space pay close attention to shifts in public perception and regulatory thinking around minor excipients, which can spark interest in citrate esters like this one. Ongoing work on bio-based and renewable raw material routes positions it as a smart bridge between the old petrochemical industry and the future of pharmaceuticals that must answer to new standards for purity, biodegradability, and safety. With generic drugmakers and innovators both running lean, reliable excipients such as Triethyl O-acetylcitrate offer peace of mind during costly, complex drug development and scale-up.
Every time I open a tablet bottle or see colorful coated pills in a pharmacy, I remember the behind-the-scenes role played by substances like Triethyl O-Acetylcitrate. This compound, derived from citric acid, doesn’t grab the spotlight with dramatic effects but quietly makes medicines more reliable and easier to take. In the pharmaceutical industry, these minor ingredients can mean the difference between a pill that works smoothly and one that falls apart.
Triethyl O-Acetylcitrate often goes straight into film coatings and capsule shells. Take extended-release pills, for example. Drug makers expect coatings to control how fast active ingredients get released or protect sensitive contents from stomach acid. As a plasticizer, Triethyl O-Acetylcitrate keeps coatings flexible — not brittle or flaky. That flexibility protects the integrity of capsules through shipping, lengthy storage, and the jostling of daily life. Without this compound, a once-effective medicine might fail before anyone swallows it.
Taste can make or break a drug’s success, especially when young patients or elderly folks with swallowing difficulties need it. Many active drug ingredients taste bitter, so manufacturers reach for masking strategies. Triethyl O-Acetylcitrate allows film distributors to hold together under different humidity and temperature conditions, helping ensure coatings do their job — making sure that unpleasant medicine taste stays locked away until it’s time to dissolve where it matters.
Unlike some other plasticizers, Triethyl O-Acetylcitrate comes with a good safety profile. Especially in children’s medications and sensitive patient populations, safety isn’t negotiable. The risk of toxicity worries both healthcare professionals and regulatory agencies, so companies have worked to move away from older plasticizers linked to side effects. Research backed by the European Food Safety Authority and the US FDA shows that Triethyl O-Acetylcitrate passes strict safety assessments when used at recommended levels. Knowing this calms fears, making it a trusted choice for companies and families alike.
Pharmaceutical tech keeps moving forward. Triethyl O-Acetylcitrate adapts well to newer, more sophisticated drug forms. Think of orally dissolving films, thinner and faster-acting than classic pills — each relying on ingredients that ensure the film stays strong but dissolves just right. In my experience working with small biotech firms, the search for ingredients that combine safety, versatility, and cost-effectiveness leads employers back to this citrate derivative more than once.
Rising demand for plant-based or naturally sourced excipients keeps pressure on chemical suppliers. Triethyl O-Acetylcitrate, synthesized from citric acid, fits well with trends toward biocompatible and environmentally considered ingredients. Regulatory standards keep tightening, so any compound with a clean record and broad utility becomes especially valuable. To keep up, manufacturers will have to watch for new testing data and keep investing in high-purity production processes.
Getting the most out of Triethyl O-Acetylcitrate depends on open communication between pharmaceutical scientists, regulators, and suppliers. Sharing real-world data about stability, taste masking, and patient experience helps everyone make better decisions. Pharmacy shelves might never advertise what’s inside that shiny coating or soft capsule, but the work that goes into making every dose safe and palatable deserves recognition.
Nothing gets attention in pharma more quickly than quality control. Triethyl O-Acetylcitrate, used as a plasticizer in tablets and capsules, directly touches lives when it slips into medicines. Pharmacopeias like BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) set out clear standards. These keep what we swallow both safe and reliable.
Take BP and EP. Both demand a high purity level, often not dropping below 99%, and look for a clear, colorless liquid. If you’ve seen lab grades, cloudiness means trouble—impurities or breakdown. Water matters, too. BP puts a sharp cap on water content, no more than 0.5%. Go above that, stability takes a hit and shelf life shortens. USP tends to match these numbers, not just for show but because real-world data shows anything less can spell recalls.
Bad batches can happen if shortcuts creep into synthesis. For Triethyl O-Acetylcitrate, regulators root out impurities—like diethyl citrate or triethyl citrate. BP, EP, and USP require heavy metals stay under 10 parts per million. If metals get in, health risks pile up, especially over long-term use. Residual solvents left from manufacturing, even in traces, can hit kidneys and nerves. Standards hammer this point home: minimal presence allowed, carefully measured for every batch.
Acidity has its place, too. If acid value creeps up, that points to hydrolysis or unwanted by-products. BP and EP want acid values under 0.2, and so do most experienced QA teams. I’ve watched extra tests run on raw materials if results flirt even close to these numbers. Quality pros trust the acid value test here—problems upstream often show up there first.
Regulators stress the importance of fingerprinting. Infrared spectra, refractive index, and relative density all act as identification tools. No shortcuts—the sample has to match reference spectra on the dot. Refractive index usually floats between 1.438 and 1.441 at 20°C for compliant material. If numbers fall outside, that batch gets red-tagged. Factory floors know this rule: one deviation, and shipments freeze before anything leaves the plant.
Assay checks take up time but save headaches. USP, BP, and EP want to see near-perfect levels—between 99.0% and 101.0%. Anything low hints at filler or degradation, high levels might mean measurement error or overconcentration. My time in quality oversight taught me to trust these guardrails. Fewer patient complaints downstream, fewer returns for the business.
For safe Triethyl O-Acetylcitrate, regular audits matter. Batch records let inspectors catch errors early. Cross-checks of water, acid value, and heavy metals in every batch mean wildcards rarely slip through. Equipment needs consistent cleaning and calibration. Staff training plays a huge role—clear standards need workers who know how to meet them, not just machines or paperwork.
Continuous monitoring by in-house and third-party labs backs up the process. Traceability means knowing exactly which lot went to which manufacturer or pharmacy. Recalls stay small—or don’t happen at all. Regulators keep raising the bar because patient safety demands nothing less.
Triethyl O-acetylcitrate, a common plasticizer, draws attention from both pharmaceutical operators and consumers. Tablets and capsules rely on excipients like this to keep coatings flexible and, sometimes, to control how quickly a drug is released in the body. For people working in formulation labs, the choice is about balancing performance, safety, and regulatory acceptance.
Any chemical used in something as sensitive as a medicine should answer clear questions: Will it build up in the body? Could it irritate? Does it trigger allergies? Triethyl O-acetylcitrate earns its spot in drugs partly because it doesn’t linger; it breaks down into citric acid and ethanol, both of which the body handles well. The Joint FAO/WHO Expert Committee on Food Additives also set an acceptable daily intake of up to 0.5 mg/kg body weight. That puts this compound in the “generally recognized as safe” column across Europe, the United States, and Japan.
People who work in pharmaceutical production know that safety isn’t just about a single study. You look for decades of use, adverse event reports, and how closely a compound follows international standards. Triethyl O-acetylcitrate has been part of oral solid dose form coatings for more than 30 years. Serious safety incidents traced back to this excipient in patient populations are vanishingly rare.
There’s plenty of published information on excipient performance in real settings. Triethyl O-acetylcitrate runs through both regulatory and scientific hoops. The U.S. Food and Drug Administration lists it as an approved indirect food additive, which speaks to low toxicity concerns when taken in the typical microgram or milligram amounts found in tablets. Studies published over the past decade have focused on digestive absorption and elimination. These studies consistently report fast metabolism and quick removal from the system.
People who have worked in quality control and regulatory affairs sometimes see worries about hypersensitivity. I’ve seen drug manufacturers take those concerns seriously in pediatric and geriatric populations. Reports on allergic reactions in public safety databases stay few, suggesting that if reactions do occur, they rarely affect large groups. My own involvement in drug product launches regularly included reviews for flavor issues or unexpected patient responses—Triethyl O-acetylcitrate simply never caused red flags.
No single excipient fits every situation. Triethyl O-acetylcitrate doesn’t always match every drug’s stability needs, especially if moisture presents a problem. A smart solution involves pre-formulation studies, combining data from both predicted behavior and stability trials, to confirm that the excipient and drug don’t interact in harmful ways. People concerned about excipients in vulnerable populations can push for excipient screening protocols that include genetic sensitivity markers and more sensitive allergy testing.
Manufacturers seeking more transparency can provide better labeling for anyone with rare sensitivities, or those concerned about cumulative exposure. Advancements in analytics let techs and quality leaders track even tiny amounts of trace byproducts, adding further assurance for users. For regulators, sharing comprehensive safety outcomes across borders cuts down on uncertainty, so that a decision in one country helps inform best practices everywhere.
People put a lot of trust in the tablet they take to relieve pain or manage chronic illness. Ensuring excipients like Triethyl O-acetylcitrate are safe and suitable means sticking to data, building on real-world safety history, and listening to end users. Voices from the lab, clinic, and patient communities matter most, and long-term transparency builds the trust these products need.
Years of working in both home kitchens and food businesses taught me one basic truth: proper storage is less about fancy systems and more about reliable routines. Let’s ground the conversation. Food’s safety, taste, and effectiveness hinge on environment. Each product—whether a bag of flour, a bottle of medication, or a box of batteries—reacts differently to air, heat, light, and humidity.
A cool, dry place sounds vague until you actually experience what moisture or temperature swings do. Mold on bread, clumpy powders, or split pills in the medicine cabinet taught me that not all cupboards work. Kitchens near ovens or sinks trap heat and humidity. Basements might feel cool, but damp air seeps into packaging. My experience lines up with what the USDA and FDA keep saying: food and medicines do best away from direct sunlight, at consistent room temperature—around 20-25°C (68-77°F). Cold garages or attic spaces lead to condensation, and extreme temperatures ruin delicate products.
For anything that claims “refrigerate after opening,” I check if I actually close it tightly. Jars jammed next to vegetables don’t stay as cold, and food left on a refrigerator door shifts temperature every time it swings open. Even with pharmaceuticals, studies show light damages some medicines, so opaque bottles or original boxes offer real protection.
Expiration dates sound like a legal CYA sometimes, but ignoring them carries risks. I’ve opened expired rice with bugs crawling out, used vitamins past their date and felt no difference, then learned later from the NIH that active ingredients really do break down. Shelf life isn’t just about spoilage. Lots of preservatives slow mold or bacteria, but chemical changes happen inside sealed packages, too.
The packaging itself matters. In my time working at a bakery, flour kept in paper bags picked up pantry odors after a month, but airtight containers stopped this. Dairy in opaque containers lasted longer, and cheese wrapped in wax paper avoided the sweaty buildup plastic caused. No one wants to waste money by tossing food, but risking stomach issues—or wasting medicine—costs even more.
Brands have to back up shelf life with real data, usually through accelerated aging tests or long-term storage studies. Health agencies, including the CDC and industry regulators, put out regularly updated guides for storage, from baby formula to household cleaners. I always check for stamps like "best before" or "use by," and I look up batch recalls online just to feel confident.
Not every product needs a vault, but careless storage hits the wallet and health. Gathering a bit of knowledge, adding a couple of airtight bins, and rotating stock—oldest to the front—makes a noticeable difference. It isn’t about feeling paranoid; it’s about being a little smarter every time you bring something home.
If unsure, I ask three questions: Does it smell or look off? Was it in harsh heat or direct sun? Is the expiry date near, or already passed? I don’t gamble on safety—either with my food or health. Whether keeping the family pantry safe or running a shop, simple steps like using sealed containers, noting dates in a visible spot, and avoiding temperature extremes prove their worth over and over.
Investing in decent storage pays off. Glass jars, sturdy plastic bins, and keeping things away from heat sources cut down on spoilage and waste. No fancy science needed—just attention and care built into daily habits.
Triethyl O-acetylcitrate has carved out a place as a film-forming plasticizer in tablets and coating systems. Many pharmaceutical technologists count on it for its safety record compared to phthalates, and patients rarely complain about its sensory footprint.
Mixing this ingredient into a formula isn’t a one-size-fits-all affair. Some lessons came the hard way: direct blending with alkaline compounds like magnesium oxide or calcium carbonate leads to instability. Over time, the migratory nature of triethyl O-acetylcitrate can cause coatings to lose elasticity. I remember a trial run for a chewable tablet line where stored samples started to crack after six months—caused, no doubt, by incompatibility between the citrate and a basic filler.
According to the Handbook of Pharmaceutical Excipients, this compound breaks down when it stays in contact with strong acids. Shelf-life drops, off-flavors pop up, and product recall becomes a real threat. Laboratory tests confirm: at low pH levels (below 3), triethyl O-acetylcitrate begins to hydrolyze, which can ruin coating integrity and taste profile. The resulting byproducts don’t just affect the look and palatability—they can even slow or speed up drug release, sometimes unpredictably.
There’s another point to consider: hygroscopicity. In environments with high humidity, film-coated tablets suck up moisture and start showing score marks or stickiness in the bottle. I’ve seen batches that failed stability studies for this reason alone. The molecular flexibility that gives triethyl O-acetylcitrate its plasticizing power also draws moisture, making tightly controlled storage a must. You won’t find this issue as often with less hydrophilic plasticizers.
Solvent choice matters, too. Using alcoholic or ketone-based solvents enhances the ease of film-coating but sometimes accelerates degradation reactions with sensitive active ingredients. Compatibility studies show that it stays relatively inert with most common flavors and sweeteners, but excipients prone to oxidation—like ascorbyl palmitate—may trigger color changes in stored tablets if paired with this citrate.
The value of pre-formulation studies grows clearer every year. Regulatory guidance—like European Pharmacopoeia monographs—insists on forced degradation tests and specific identification of excipient-drug interactions. Neglecting this step courts real risk: a failed product not only hurts patient trust but can open the door to legal and regulatory headaches. Years ago, pharmacists flagged an entire lot of coated antibiotics for discoloration, traced back to a reaction with a subpar batch of plasticizer.
Research points to better outcomes with sealed, moisture-resistant packaging and desiccant use. Some teams switched to alternative citrate-based plasticizers or added anti-caking agents to counter water uptake. Expert consensus from the International Pharmaceutical Excipients Council stresses maintaining formulation pH between 4 and 7 to sidestep most hydrolysis worries. This ensures that triethyl O-acetylcitrate does its job without letting down expectations for shelf life and safety.
For teams just starting with this plasticizer, it pays to ask hard questions up front. Will the excipients react over time? Which stress conditions push the system to breakdown? Could a slight tweak—like microcrystalline cellulose instead of calcium carbonate—boost performance? Back these choices with published stability data and your own test records. In my experience, successful launches rarely come from guesswork.
Triethyl O-acetylcitrate won’t give trouble if handled right. Treat it as a partner that asks for care, testing, and the right match of ingredients. It rewards attention to detail with clean, reproducible coatings and a more stable product on pharmacy shelves.
| Hazards | |
| Autoignition temperature | > 210°C |
Chengguan District, Lanzhou, Gansu, China
